Interferon alpha-2b treatment of chronic posttransfusion non-A, non-B hepatitis: interim results of a randomized controlled open study

Scandinavian Journal of Infectious Diseases
O WeilandA Frydén

Abstract

32 patients with biopsy-proven chronic non-A, non-B posttransfusion hepatitis and raised aminotransferase levels since more than 1 year were randomized 2:1 to treatment with interferon alpha-2b, Introna, or to controls. The interferon group received 3 MU interferon 3 times weekly subcutaneously. Interim results 12 weeks after randomization showed that 14/21 (67%) patients in the treatment group had normalized their serum alanine aminotransferase levels whereas none of 11 patients in the control group had (p less than 0.001). If interferon alpha-2b is only suppressive during ongoing therapy or curative will be shown later during continued follow-up.

References

Jan 1, 1988·Scandinavian Journal of Infectious Diseases·R SchvarczH Glaumann
Dec 18, 1986·The New England Journal of Medicine·J H HoofnagleE A Jones
Nov 1, 1987·Scandinavian Journal of Gastroenterology·R WejstålG Norkrans
Jan 1, 1985·Scandinavian Journal of Gastroenterology. Supplement·H C ThomasL J Scully

❮ Previous
Next ❯

Citations

Jul 1, 1991·Gastroenterologia Japonica·T MorizaneM Tsuchiya
Sep 1, 1990·Baillière's Clinical Gastroenterology·N Sheron, G J Alexander
Jan 5, 2002·Expert Opinion on Investigational Drugs·N N Zein
Jan 29, 1999·Hematology/oncology Clinics of North America·D DiMichele, E J Neufeld
Sep 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R L Koretz
Dec 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N ManabeJ A Grimaud
Jun 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M ShindoJ H Hoofnagle
Oct 1, 1992·Journal of Chemotherapy·R Terranova, S Luca
Jan 1, 1989·Scandinavian Journal of Infectious Diseases. Supplementum·L Mattsson
Apr 20, 2005·Contemporary Clinical Trials·Fabio TinèLuigi Pagliaro
Jun 1, 1996·Pediatric Clinics of North America·D DiMichele

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Hematology
O D Ratnoff, P K Jones
American Journal of Hematology
D P LillicrapA R Giles
© 2022 Meta ULC. All rights reserved